Grail expected to be first FDA-approved multi-cancer test, says CEO Bob Ragusa
0
0
25/06/24
Dans
Amérique du Nord / États-Unis
Grail CEO Bob Ragusa joins CNBC's 'Squawk Box' to discuss the company's debut on the Nasdaq, how Grail is innovating early cancer detection, and more.
Montre plus
0 commentaires
sort Trier par
